Douglass Winthrop Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,576
| Closed | -$225K | – | 291 |
|
|
2024
Q2 | $225K | Sell |
1,576
-30
| -2% | -$4.28K | ﹤0.01% | 263 |
|
|
2024
Q1 | $206K | Buy |
+1,606
| New | +$206K | ﹤0.01% | 272 |
|
|
2018
Q3 | – | Sell |
-28,600
| Closed | -$660K | – | 278 |
|
|
2018
Q2 | $660K | Sell |
28,600
-2,600
| -8% | -$60K | 0.03% | 176 |
|
|
2018
Q1 | $768K | Sell |
31,200
-2,376
| -7% | -$58.5K | 0.04% | 161 |
|
|
2017
Q4 | $901K | Sell |
33,576
-5,624
| -14% | -$151K | 0.05% | 137 |
|
|
2017
Q3 | $944K | Hold |
39,200
| – | – | 0.05% | 125 |
|
|
2017
Q2 | $841K | Buy |
39,200
+2,600
| +7% | +$55.8K | 0.05% | 130 |
|
|
2017
Q1 | $627K | Buy |
36,600
+1,000
| +3% | +$17.1K | 0.04% | 143 |
|
|
2016
Q4 | $638K | Buy |
35,600
+14,812
| +71% | +$265K | 0.04% | 139 |
|
|
2016
Q3 | $432K | Buy |
20,788
+386
| +2% | +$8.02K | 0.03% | 168 |
|
|
2016
Q2 | $549K | Sell |
20,402
-2,000
| -9% | -$53.8K | 0.04% | 150 |
|
|
2016
Q1 | $607K | Sell |
22,402
-3,000
| -12% | -$81.3K | 0.04% | 147 |
|
|
2015
Q4 | $738K | Buy |
25,402
+8,482
| +50% | +$246K | 0.05% | 140 |
|
|
2015
Q3 | $459K | Sell |
16,920
-35,270
| -68% | -$957K | 0.04% | 164 |
|
|
2015
Q2 | $1.39M | Hold |
52,190
| – | – | 0.11% | 97 |
|
|
2015
Q1 | $1.39M | Buy |
52,190
+38,400
| +278% | +$1.02M | 0.11% | 97 |
|
|
2014
Q4 | $292K | Sell |
13,790
-80
| -0.6% | -$1.69K | 0.03% | 174 |
|
|
2014
Q3 | $330K | Sell |
13,870
-2,000
| -13% | -$47.6K | 0.03% | 158 |
|
|
2014
Q2 | $367K | Sell |
15,870
-1,000
| -6% | -$23.1K | 0.03% | 144 |
|
|
2014
Q1 | $385K | Buy |
+16,870
| New | +$385K | 0.04% | 135 |
|